IMCL

Icahn_image

Icahn Wins Blue Ribbon in ImClone Race (IMCL, LLY, BMY, MRK)

Carl Icahn appears to have won a blue ribbon for ImClone Systems (NASDAQ: IMCL) shareholders.  The biotech stock is trading up on a very weak trading day after what many ...
Read Full Story »
Newspaper

Media Digest 10/2/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, the economic bailout bill passed the Senate and is likely to pass the House.Reuters reports that GE (GE) raised $15 billion with some of the capital coming ...
Read Full Story »
Newspaper

Media Digest 9/29/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, Congress is ready to vote on a $700 billion financial bailout package.Reuters reports that Belgian-Dutch group Fortis was nationalizedReuters reports that British mortgage lender Bradford & Bingley ...
Read Full Story »
Icahn_image

Higher ImClone Bid Challenges Icahn At His Own Game (IMCL, BMY)

ImClone Systems Inc. (NASDAQ: IMCL) is among the biotech bonanza merger candidates with one deal on the table and perhaps an unofficial deal waiting in the wings.  Bristol-Myers Squibb Co. ...
Read Full Story »

Bristol-Myers Re-Offers No New Offer for ImClone (IMCL, BMY)

Bristol-Myers Squibb (NYSE: BMY) has sent a letter to Imclone Systems (NASDAQ: IMCL) in response to yesterday's rejection of its buyout offer.  It said it is disappointed that the $60.00 ...
Read Full Story »
Newspaper

Media Digest 9/11/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, Washington Mutual (WM) fell 30% to a 17-year low.Reuters reports that billionaire Carlos Slim has bought 6% of The New York Times (NYT).Reuters writes that Northrop Grumman ...
Read Full Story »

Day Trader Alert: ImClone Systems (IMCL, BMY)

ImClone Systems Inc. (NASDAQ: IMCL) is a biotech buyout bonanza stock that traders and investors have been watching closely.  The company has said that the proposed $60.00 per share cash ...
Read Full Story »
Newspaper

Media Digest 8/5/2008 Reuters, WSJ, NYTImes, FT, Bloomberg

According to Reuters, large Yahoo! (YHOO) holder Capital Research want to know whether vote counts from the company's annula meeting were accurate.Reuters writes that the Fed is seen as holding ...
Read Full Story »
Erbitux_logo_2

Icahn & ImClone Merger Game with Bristol-Myers: Bluff vs. Chicken (IMCL, BMY)

Carl Icahn and friends at ImClone Systems Incorporated (NASDAQ: IMCL) have now formally responded to Bristol-Myers Squibb Company (NYSE: BMY) regarding the cash buyout of the company.  The company's board ...
Read Full Story »

Top Pre-Market Analyst Downgrades (FMR, GOL, HNSN, IMCL, MNST, OSIR, WYE)

These are some of the key downgrades or negative calls we are seeing from analysts this Friday morning with more than two hours to the open:First Mercury (FMR) Cut to ...
Read Full Story »

Icahn, ImClone, Bristol-Myers… A 3-Way Marriage (IMCL, BMY)

Another biotech giant is biting the dust via a buyout offer.  ImClone Systems Inc. (NASDAQ: IMCL) has been given a buyout offer from Bristol-Myers (NYSE: BMY) at $60.00 per share.As ...
Read Full Story »

ERBITUX Gets Approved in Japan for Colorectal Cancer (IMCL, BMY)

ImClone Systems Incorporated (NASDAQ: IMCL) has just announced that ERBITUX(R) has received marketing authorization in Japan for use in treating patients with advanced or metastatic colorectal cancer (mCRC). This approval ...
Read Full Story »

Can Carl Icahn Fix Broken Biotechs? (ANX, BIIB, ENZN, IMCL, TELK, FOLD, AMLN, REGN)

Carl Icahn is a billionaire financier, activist, and investor.  Most think of Icahn as an activist investor that wants to get inside and drive value without having to acquire the ...
Read Full Story »

Biotech Business Daily (AMAG, CEGE, IMCL, XOMA, TRCA)

AMAG Pharmaceuticals (NASDAQ: AMAG) has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI) beginning May 19, 2008. AMAG shares up $1.26 at $39.85. The 52-week range is $38.16 to ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (AIG, BBW, CPST, LNG, CMC, DLTR, IMCL, PSUN, TDSC, TAL)

These are ten of the top analyst calls we are seeing this Monday morning:American International Group (NYSE: AIG) Cut to Neutral from Buy at Goldman Sachs.Build-A-Bear Workshop (NYSE: BBW) Cut ...
Read Full Story »